-
Eurofins Genomics US Expands Gene Synthesis Capabilities
contractpharma
August 12, 2019
Acquires Blue Heron Biotech, known for expertise in gene synthesis and sub cloning ...
-
New DNA Blood Test May Help Guide Breast Cancer Treatment
drugs
August 09, 2019
Could the DNA from a patient's breast tumor help doctors spot whether stray cancer cells are still in her blood?
-
DNA Methylation Classifier Predicts Progression in CIN2
drugs
August 07, 2019
A DNA methylation classifier can predict progression in young women with untreated cervical intraepithelial neoplasia grade 2 (CIN2), according to a study published online in Clinical Infectious Diseases.
-
China set to begin Phase II HIV vaccine trials
europeanpharmaceuticalreview
July 23, 2019
A vaccine containing the DNA of HIV is poised to enter a Phase II trial, making it the first vaccine of its kind to do so.
-
How to Protect Your DNA for Big Health Benefits
drugs
July 17, 2019
You might think that stress affects you only emotionally or that a lack of sleep simply leaves you feeling cranky.
-
First Patient Dosed with DNA-based, Neoantigen-Targeting Personalized Vaccine from Geneos
americanpharmaceuticalreview
July 12, 2019
Geneos Therapeutics, a clinical-stage biotech company, a spin-out of Inovio Pharmaceuticals, announced the first cancer patient was dosed using the company's GT-EPIC Neoantigen-Targeting Personalized Vaccine Technology.
-
Artificial DNA can control release of active ingredients from drugs
worldpharmanews
July 01, 2019
Artificial DNA can control release of active ingredients from drugs.
-
Mouth Rinse for HPV DNA May Be Biomarker in Head, Neck Cancer
drugs
June 11, 2019
Mouth Rinse for HPV DNA May Be Biomarker in Head, Neck Cancer.
-
Fragmentation Profiles of Cell-Free DNA Can Detect Cancer
drugs
June 06, 2019
Fragmentation Profiles of Cell-Free DNA Can Detect Cancer.
-
Aldevron to Build 14-Acre Gene Therapy Mfg. Campus
contractpharma
June 04, 2019
Annual capacity will exceed $1 billion of plasmid DNA, RNA, gene editing enzymes, and other biologics.